Non-randomised evaluations of strategies to increase participant retention in randomised controlled trials: a systematic review.
Drop-outs
Non-randomised evaluations
Participant retention
Randomised trials
Retention strategies
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
29 09 2020
29 09 2020
Historique:
received:
05
08
2019
accepted:
31
08
2020
entrez:
30
9
2020
pubmed:
1
10
2020
medline:
25
6
2021
Statut:
epublish
Résumé
Retention of participants is essential to ensure the statistical power and internal validity of clinical trials. Poor participant retention reduces power and can bias the estimates of intervention effect. There is sparse evidence from randomised comparisons of effective strategies to retain participants in randomised trials. Currently, non-randomised evaluations of trial retention interventions embedded in host clinical trials are rejected from the Cochrane review of strategies to improve retention because it only included randomised evaluations. However, the systematic assessment of non-randomised evaluations may inform trialists' decision-making about retention methods that have been evaluated in a trial context.Therefore, we performed a systematic review to synthesise evidence from non-randomised evaluations of retention strategies in order to supplement existing randomised trial evidence. We searched MEDLINE, EMBASE, and Cochrane CENTRAL from 2007 to October 2017. Two reviewers independently screened abstracts and full-text articles for non-randomised studies that compared two or more strategies to increase participant retention in randomised trials. The retention trials had to be nested in real 'host' trials ( including feasibility studies) but not hypothetical trials. Two investigators independently rated the risk of bias of included studies using the ROBINS-I tool and determined the certainty of evidence using GRADE (Grading of Recommendations Assessment, Development and Evaluation) framework. Fourteen non-randomised studies of retention were included in this review. Most retention strategies (in 10 studies) aimed to increase questionnaire response rate. Favourable strategies for increasing questionnaire response rate were telephone follow-up compared to postal questionnaire completion, online questionnaire follow-up compared to postal questionnaire, shortened version of questionnaires versus longer questionnaires, electronically transferred monetary incentives compared to cash incentives, cash compared with no incentive and reminders to non-responders (telephone or text messaging). However, each retention strategy was evaluated in a single observational study. This, together with risk of bias concerns, meant that the overall GRADE certainty was low or very low for all included studies. This systematic review provides low or very low certainty evidence on the effectiveness of retention strategies evaluated in non-randomised studies. Some strategies need further evaluation to provide confidence around the size and direction of the underlying effect.
Sections du résumé
BACKGROUND
Retention of participants is essential to ensure the statistical power and internal validity of clinical trials. Poor participant retention reduces power and can bias the estimates of intervention effect. There is sparse evidence from randomised comparisons of effective strategies to retain participants in randomised trials. Currently, non-randomised evaluations of trial retention interventions embedded in host clinical trials are rejected from the Cochrane review of strategies to improve retention because it only included randomised evaluations. However, the systematic assessment of non-randomised evaluations may inform trialists' decision-making about retention methods that have been evaluated in a trial context.Therefore, we performed a systematic review to synthesise evidence from non-randomised evaluations of retention strategies in order to supplement existing randomised trial evidence.
METHODS
We searched MEDLINE, EMBASE, and Cochrane CENTRAL from 2007 to October 2017. Two reviewers independently screened abstracts and full-text articles for non-randomised studies that compared two or more strategies to increase participant retention in randomised trials. The retention trials had to be nested in real 'host' trials ( including feasibility studies) but not hypothetical trials. Two investigators independently rated the risk of bias of included studies using the ROBINS-I tool and determined the certainty of evidence using GRADE (Grading of Recommendations Assessment, Development and Evaluation) framework.
RESULTS
Fourteen non-randomised studies of retention were included in this review. Most retention strategies (in 10 studies) aimed to increase questionnaire response rate. Favourable strategies for increasing questionnaire response rate were telephone follow-up compared to postal questionnaire completion, online questionnaire follow-up compared to postal questionnaire, shortened version of questionnaires versus longer questionnaires, electronically transferred monetary incentives compared to cash incentives, cash compared with no incentive and reminders to non-responders (telephone or text messaging). However, each retention strategy was evaluated in a single observational study. This, together with risk of bias concerns, meant that the overall GRADE certainty was low or very low for all included studies.
CONCLUSIONS
This systematic review provides low or very low certainty evidence on the effectiveness of retention strategies evaluated in non-randomised studies. Some strategies need further evaluation to provide confidence around the size and direction of the underlying effect.
Identifiants
pubmed: 32993797
doi: 10.1186/s13643-020-01471-x
pii: 10.1186/s13643-020-01471-x
pmc: PMC7523052
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
224Subventions
Organisme : Chief Scientist Office
ID : HSRU1
Pays : United Kingdom
Références
CJEM. 2018 Jan;20(1):148-153
pubmed: 28065207
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
BMJ Open. 2017 Mar 20;7(3):e015276
pubmed: 28320800
Trials. 2014 Jan 23;15:32
pubmed: 24456928
J Clin Epidemiol. 2011 Dec;64(12):1294-302
pubmed: 21803546
J Clin Epidemiol. 2015 Dec;68(12):1481-7
pubmed: 26186981
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
J Clin Epidemiol. 2011 Dec;64(12):1283-93
pubmed: 21839614
J Clin Epidemiol. 2016 Nov;79:90-95
pubmed: 27321820
BMJ. 1999 Jul 31;319(7205):312-5
pubmed: 10426754
Clin Trials. 2004;1(4):368-76
pubmed: 16279275
J Interpers Violence. 2019 Jul;34(13):2774-2796
pubmed: 27503325
Cochrane Database Syst Rev. 2018 Feb 22;2:MR000013
pubmed: 29468635
Contemp Clin Trials. 2008 Sep;29(5):705-10
pubmed: 18565801
Ann Epidemiol. 2004 Jan;14(1):66-72
pubmed: 14664782
J Clin Epidemiol. 2012 Jan;65(1):90-9
pubmed: 21831595
Syst Rev. 2018 Feb 20;7(1):30
pubmed: 29458415
Clin Trials. 2013 Oct;10(5):775-82
pubmed: 23983157
Cochrane Database Syst Rev. 2014 Apr 29;(4):MR000034
pubmed: 24782322
J Public Health Med. 1997 Jun;19(2):219-21
pubmed: 9243440
J Clin Epidemiol. 2014 Jun;67(6):622-8
pubmed: 24508144
BMC Med Res Methodol. 2007 Feb 27;7:12
pubmed: 17326837
J Clin Epidemiol. 2015 Dec;68(12):1446-50
pubmed: 25709076
Arch Dis Child. 2008 Jun;93(6):458-61
pubmed: 18495909
Trials. 2017 Aug 31;18(1):406
pubmed: 28859674
Trials. 2018 Feb 23;19(1):139
pubmed: 29475444
J Epidemiol Community Health. 2010 Jul;64(7):580-4
pubmed: 20547698
US Army Med Dep J. 2015 Oct-Dec;:24-30
pubmed: 26606405
BMC Med Res Methodol. 2012 Sep 24;12:148
pubmed: 23006680
Clin Trials. 2015 Apr;12(2):156-65
pubmed: 25518956
Prev Med Rep. 2015 Sep 05;2:746-9
pubmed: 26844146
Control Clin Trials. 2004 Feb;25(1):31-52
pubmed: 14980747
Cochrane Database Syst Rev. 2013 Dec 03;(12):MR000032
pubmed: 24297482
BMC Med Res Methodol. 2012 Nov 23;12:178
pubmed: 23176384
Cochrane Database Syst Rev. 2007 Apr 18;(2):MR000008
pubmed: 17443629
BMJ. 2008 May 10;336(7652):1049-51
pubmed: 18467413
J Clin Epidemiol. 2011 Dec;64(12):1277-82
pubmed: 21802904
BMC Med Res Methodol. 2008 Jan 31;8:2
pubmed: 18237377
BMJ. 1999 Sep 11;319(7211):670-4
pubmed: 10480822
BMC Res Notes. 2014 Sep 11;7:632
pubmed: 25213806
J Clin Epidemiol. 2011 Dec;64(12):1303-10
pubmed: 21802903
BMJ. 2013 Jun 06;346:f3438
pubmed: 23744649
J Med Internet Res. 2013 Dec 11;15(12):e278
pubmed: 24334216
J Clin Epidemiol. 2011 Apr;64(4):407-15
pubmed: 21247734